** Shares in Vetoquinol VETO.PA fall around 4% after the French veterinary pharmaceutical company reported lower nine-month sales
** Its nine-month sales were down 3.5% on a reported basis to 384.2 million euros
** "Industrial transition weighs on Q3," says TP ICAP Midcap, citing temporary supply disruptions from internal production transfers of key products
** The broker cuts its rating on the stock to "hold" from "buy" and lowers its PT by 4% to 88 euros
** If losses hold, Vetoquinol shares will see their worst day since late April
(Reporting by Lucie Barbier)
((lucie.barbier@thomsonreuters.com))